Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1881 of 6351
-
Can an herbal tablet shrink gallbladder polyps without surgery?
Disease control CompletedThe primary aim of this study is to evaluate the efficacy and safety of Danning Tablets in the treatment of MGPs. Specifically, the study seeks to determine whether Danning Tablets, when used alongside standard care, can effectively reduce the size of MGPs and improve related sym…
Phase 4 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New injection hopes to heal scarred vocal cords and restore voice
Symptom relief OngoingThe purpose of this study is to confirm the efficacy and safety of KP-100LI, a intracordal formulation containing recombinant human dHGF as the active pharmaceutical ingredient, for voice function improvement therapy in patients with vocal fold scar (including vocal fold sulcus).
Phase 3 • Sponsor: Kringle Pharma, Inc. • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
New drug targets stubborn tremors in Parkinson's
Symptom relief CompletedThis is a 17-week double-blind, placebo-controlled, randomized, flexible-dosing, parallel-group, multicenter study designed to evaluate the efficacy and safety of suvecaltamide for the treatment of moderate to severe residual tremor in adult participants with Parkinson's disease …
Phase 2 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Could magnetic pulses lift depression in schizophrenia?
Symptom relief Recruiting nowAround 40% of schizophrenia patients present depressive symptoms, which are associated with elevated suicide and violence risk and poor prognosis and quality of life. Recent meta-analysis showed the effect size of antidepressants for depressive symptoms of schizophrenia patients …
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Glowing dye and 3D maps help surgeons remove lung cancer with less damage
Symptom relief Recruiting nowWith the advent of CT screening for lung cancer, an increasing number of NSCLCs are being detected at very early stages, and the demand for pulmonary segmentectomy is rising rapidly. As such, there is a need to develop new surgical techniques to facilitate minimally invasive pulm…
Phase 1/2 • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Text messages empower HIV-positive women to take control of family planning
Disease control OngoingUse of a mobile health (mHealth) intervention to provide reproductive life counseling to women living with HIV may improve delivery of integrated reproductive health/HIV services and prevent adverse reproductive health outcomes. The proposed study will evaluate SMS platform and r…
Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Shock and awe: new combo therapy sparks hope for paraplegia recovery
Disease control CompletedTraumatic Spinal Cord Injury (TSCI) is a catastrophic, unexpected, and devastating event that can occur along the spinal column (cervical, thoracic, and lumbar). Traditional views describe the spinal cord as a protected bundle of nerves connecting the brain to the body. TSCI ofte…
Sponsor: Lebanese University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Battle of the balloons: super High-Pressure vs shockwaves for Rock-Hard arteries
Disease control CompletedThe ISAR-CALC 2 trial is an investigator-initiated, prospective, randomized, multicenter, assessors-blind, open-label other clinical investigation. The objective of this trial is to investigate final angiographic minimal lumen diameter (MLD) following a strategy of super high-pre…
Sponsor: Deutsches Herzzentrum Muenchen • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New pill combo takes on Hard-to-Treat cancers
Disease control OngoingThe purpose of this clinical trial is to learn the safety and effects of the study medicine (PF-07799544) alone or in combination as a potential cancer treatment for adults with advanced solid tumors. The study will be conducted in two parts: PF-07799544 as a single agent (Phase …
Phase 1 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Three-Drug immune cocktail takes on pancreatic cancer
Disease control PausedThis study is being done to test the safety and effectiveness of combining domvanalimab (AB154), zimberelimab (AB122), and APX005M with pancreatic cancer that has spread to other parts of body. This research study involves immunotherapy. Immunotherapy triggers the body's immune …
Phase 1/2 • Sponsor: James Cleary, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New study tests if menstrual cycle timing boosts Quit-Smoking success
Disease control Recruiting nowTobacco use is a risk factor for at least 20 types of cancer and remains the leading preventable cause of cancer in Canada. Smoking cessation is an important cancer prevention strategy for the close to 2 million Canadian women who currently smoke. However, findings from controlle…
Phase 4 • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Ultrasound opens brain barrier to deliver Parkinson's drug in first human test
Disease control Recruiting nowThe goal of this study is to establish safety and feasibility of intracerebral delivery of GCase via MRgFUS. This technique may offer potential benefits given the exposure of the putamen to GCase in animal models has been shown to be efficacious in improving Parkinson's disease p…
Sponsor: InSightec • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Mouthwash test may spot hidden throat cancer
Diagnosis CompletedThe purpose of this research is to evaluate a new test for oral HPV DNA in saliva ('oral rinse test').
Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
New hope for rare disease: experimental drug targets PMM2-CDG
Disease control CompletedThis is a Phase 2, randomized, open-label, 24-week treatment study to evaluate the potential pharmacodynamic (PD) activity, safety, tolerability, and pharmacokinetics (PK) of GLM101 in adult, adolescent, and pediatric, patients with a confirmed diagnosis of PMM2-CDG. The planned …
Phase 2 • Sponsor: Glycomine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New dialysis graft aims to reduce blockages and infections
Disease control OngoingThis study is a single site, prospective, single arm evaluation of the safety and effectiveness of the Healionics STARgraft-3 hemodialysis access graft. STARgraft devices have been demonstrated in preclinical and other studies to have improved resistance to the common failure mod…
Sponsor: Healionics Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Diet and supplements tested to stop blood cancer before it starts
Prevention Recruiting nowThe researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM)…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Text and phone support helps cervical cancer survivors kick the habit
Disease control OngoingThe goal of this research study is to compare the efficacy of a treatment approach that comprises both Motivation And Problem-Solving (MAPS)-based telephone counseling and a personally-tailored SMS-delivered text-based approach to quitline-delivered smoking cessation treatment to…
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a new pill boost brain function in early Alzheimer's?
Symptom relief CompletedThe primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Alzheimer's Disease.
Phase 2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 17:13 UTC
-
New antibody IMT-009 tested in patients with advanced cancers
Disease control OngoingThis is a Phase 1/2a open-label, multicenter, dose escalation and dose expansion trial in which IMT-009 will be administered by the intravenous (IV) route to participants with solid tumors or lymphomas. The main goals of this study are to: * Find the recommended dose of IMT-009…
Phase 1/2 • Sponsor: Immunitas Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New RA strategy: switch drugs after 12 weeks for better control?
Disease control Recruiting nowIn rheumatoid arthritis (RA), the consensual 1st line conventional synthetic disease modifying antirheumatic drugs (csDMARD) of RA is methotrexate (MTX). In case of contra-indication or intolerance to MTX, leflunomide is an alternative. If the treatment target is not achieved wit…
Phase 3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC